Characterizing TP53 mutations in bone and soft tissue sarcoma

被引：0
|
作者：
Babatunde, Olayode
Notti, Ryan Quin
Tap, William D.
机构：
[1] Mem Sloan Kettering Canc Ctr Fellowship GME Off, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Sarcoma Med Oncol Serv, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23521
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TP53 mutations in human skin cancers
    Giglia-Mari, G
    Sarasin, A
    HUMAN MUTATION, 2003, 21 (03) : 217 - 228
  • [42] Context Determines Effects of TP53 Mutations
    Haloupek, Nicole
    CANCER DISCOVERY, 2020, 10 (11) : 1616 - 1616
  • [43] TP53 mutations and MDS - not as easy as it seems
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 7 - 8
  • [44] TP53 Mutations in Uterine Atypical Leiomyomas
    Kuhn, E.
    Yemelyanova, A.
    Wang, T-L
    Kurman, R. J.
    Shih, I-M
    LABORATORY INVESTIGATION, 2012, 92 : 281A - 282A
  • [45] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
    Grossmann, Vera
    Artusi, Valentina
    Schnittger, Susanne
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Haferlach, Torsten
    Haferlach, Claudia
    Kern, Wolfgang
    Kohlmann, Alexander
    BLOOD, 2011, 118 (21) : 778 - 778
  • [46] TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia
    Cucchi, David G. J.
    Bachas, Costa
    Klein, Kim
    Huttenhuis, Sander
    Zwaan, Christian M.
    Ossenkoppele, Gert J.
    Janssen, Jeroen M. W. M.
    Kaspers, Gertjan L.
    Cloos, Jacqueline
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 736 - 739
  • [47] Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions
    Das, Sunetra
    Idate, Rupa
    Lana, Susan E.
    Regan, Daniel P.
    Duval, Dawn L.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [49] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [50] A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL
    Yang, Kaiyun
    Wang, Justin
    Kanwar, Nisha
    Villani, Anita
    Ajani, Olufemi
    Fleming, Adam
    Patil, Vikas
    Mamatjan, Yasin
    Wei, Qingxia
    Malkin, David
    Shlien, Adam
    Zadeh, Gelareh
    Provias, John
    BRAIN TUMOR PATHOLOGY, 2022, 39 (04) : 225 - 231
12345